Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology)

AIM OF THE STUDY: Systemic chemotherapy for patients with pancreatic cancer has limited impact on overall survival (OS). Patients eligible for chemotherapy should be selected carefully. The aim of the study was to search for prognostic factors for survival in patients with gemcitabine (Gem)-refracto...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Contemp Oncol (Pozn)
Main Authors: İnal, Ali, Kos, F. Tuba, Algın, Efnan, Yıldız, Ramazan, Berk, Veli, Unek, İlkay T., Colak, Dilsen, Dane, Faysal, Geredeli, Caglayan, Isıkdogan, Abdurrahman
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2015
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4444440/
https://ncbi.nlm.nih.gov/pubmed/26034390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2014.43933
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados